Optiscan Imaging (OIL.AX) Hisse Fiyat
Optiscan Imaging Fiyat
Optiscan Imaging şirketinin geliri, son 19 yılda yıllık %12,5 daralarak 448.769,00 AUD seviyesine geriledi. Optiscan Imaging şirketinde net marj %-1.556,7 seviyesinde bulunuyor; birkaç yıl önceki %-417,9 seviyesine göre geriledi.
Optiscan Imaging hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Optiscan Imaging iş modeli ve hisse analizi
Optiscan Imaging hakkında sık sorulan sorular
The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.
Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.
The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.
Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.
Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.
Optiscan Imaging Ltd is primarily present in Australia.
Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.
Güncel döviz kuruyla Optiscan Imaging hissesi 0,10 EUR (0,16 AUD) seviyesindedir.
Optiscan Imaging hissesi (OIL.AX) 1 borsada işlem görür, bunlar arasında: ASX (OIL.AX).
Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.
'nin Optiscan Imaging hasılatı 448.769,00 AUD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
'nin Optiscan Imaging karı -6,99 M AUD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Optiscan Imaging'nin Fiyat/Kazanç (F/K) oranı şu anda -23,91'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Optiscan Imaging hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Optiscan Imaging'nin Fiyat/Satış (F/S) oranı şu anda 372,28'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Optiscan Imaging hisse senedinin değerleme metriği olarak hizmet eder.
Optiscan Imaging'nin Eulerpool Kalite Puanı 4/10'dur.
Optiscan Imaging'nin ISIN'i AU000000OIL4'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Optiscan Imaging'nin WKN'i 932111'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Optiscan Imaging'nin ticker'ı OIL.AX'dir. Ticker sembolü, Optiscan Imaging hisseleri borsada işlem görmek için kullanılır.
Optiscan Imaging Hissesi
Optiscan Imaging Emsaller Grubu
Optiscan Imaging Ticker
Optiscan Imaging FIGI
Optiscan Imaging'nin tüm temel göstergeleri ve derinlemesine analizi
Optiscan Imaging hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Optiscan Imaging şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: